Skip to Content

GRIS-PEG 250 (Griseofulvin (Ultramicrocrystalline) 250 mg)

Pill with imprint GRIS-PEG 250 is White, Capsule-shape and has been identified as Griseofulvin (Ultramicrocrystalline) 250 mg. It is supplied by Oceanside Pharmaceuticals, Inc..

Griseofulvin is used in the treatment of dermatophytosis; onychomycosis, toenail; tinea barbae; onychomycosis, fingernail; tinea capitis and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Griseofulvin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GRIS-PEG 250

Griseofulvin (ultramicrocrystalline) 250 mg GRIS-PEG 250

Griseofulvin (Ultramicrocrystalline)

Imprint
GRIS-PEG 250
Strength
250 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antifungals
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Oceanside Pharmaceuticals, Inc.
National Drug Code (NDC)
68682-0520

Get help with Imprint Code FAQs.

Related Images for "GRIS-PEG 250"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.